ContractDistributorship Agreement • March 1st, 2017 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances
Contract Type FiledMarch 1st, 2017 Company IndustryTHIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.